StonvexLoading…
StonvexStonvexStonvexCore line items from AR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.14B | $4.30B | $4.48B | $8.71B |
Operating Income | $883.65M | $460.00K | $396.25M | $2.54B |
Net Income | $674.57M | $93.70M | $297.33M | $2.00B |
EPS (Diluted) | $2.03 | $0.18 | $0.64 | $5.69 |
Total Assets | $13.25B | $13.01B | $13.52B | $14.12B |
Total Liabilities | $5.53B | $5.79B | $6.38B | $7.10B |
Cash & Equivalents | $210.00M | $0.00 | $0.00 | $0.00 |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $2.11B |
Shares Outstanding | 308.51M | 311.17M | 303.54M | 297.36M |